AAA. A. Aniskin

A. A. Aniskin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


A. A. Aniskin has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of preoperative therapy on surgical shrinkage in rectal cancer

    by A. S. Gorbunova, Z. Z. Mamedli, А. А. Аniski, D. V. Kuzmichev, N. A. Kozlov, А. К. Tsutsaev, F. M. Abdul, А. I. Каpkovа

    Background. The possibility of performing a surgical margin of less than 2 cm without increasing the risk of recurrence is an important problem. Most studies were conducted on a specimen examined after resection and formalin fixation without taking into account tissue contraction – surgical shrinkage. The effect of neoadjuvant treatment combinations on surgical shrinkage is also not determined.Aim. To study the effect of shrinkage of the distal margin of resection of the rectum in colorectal cancer after formalin fixation, as well as the effect of preoperative therapy on the shrinkage.Materials and methods. In total, 183 patients with histologically verified rectal and sigmoid colon cancer (adenocarcinoma G1–3) who underwent surgical treatment were prospectively analyzed. The distance between the lower pole of the tumor and the distal resection margin was measured immediately after excision. Then, this parameter was measured after fixation of the specimen in 10 % formalin solution.Results. Median rectal shrinkage after formalin fixation of the specimen was 22.46 % in the surgical treatment group and 19.27 % in the radiation therapy group. In 101 cases, rectal shrinkage was more than 20 %. A statistically significant difference was found in the incidence of surgical shrinkage more than 20 % in the group of patients who did not receive radiotherapy (p = 0.045).No statistically significant relationship was found between surgical shrinkage and gender (p = 0.135), tumor location (p = 0.082), or tumor advancement (p = 0.355). There was also no statistical significance between surgical shrinkage and the type of surgery (p = 0.225).Conclusion. Measurement of the distal resection margin under different conditions influences the assessment of oncologic clearance when interpreting pathological findings and determining treatment outcomes. Radiotherapy is associated with higher probability of a lower degree of rectal shrinkage, which may be of significant importance in surgical treatment.

  • Open Access

    Distal resection margin in colorectal surgery in vivo and after formalin fixation

    by A. S. Gorbunova, A. A. Aniskin, D. V. Kuzmichev, Z. Z. Mamedli, A. V. Polynovsky, A. A. Lovenger, F. M. Abdul

    Introduction. Historically, the standard for distal margin in rectal cancer surgery has been the 5 cm «rule». Currently, there is a trend to reduction the distal surgical margin. However, intraoperative specimen measurements and histological examination data differ. The phenomenon of surgical shrinkage plays a significant role, especially in determining the distal resection margin, as intraoperative data may not coincide with measurement after fixation of the specimen. Possible differences may lead to doubts about the oncological adequacy of the performed resection boundaries.Aim. To examine the shrinkage effect of distal resection margin in colorectal cancer after organ formalin fixation.Materials and methods. The prospective analysis included data of 20 patients with histologically confirmed rectal cancer and sigmoid cancer (adenocarcinoma G1–3) for whom surgical treatment is recommended. The distance between the lower edge of tumor to the distal resection margin was measured after resection (in vivo) and after 5–12 minutes after the last measurement. Then the determination of this distance was made after formalin fixation (in vitro).Results. The analysis revealed that the average shrinkage of the distal resection margin from in vivo to ex vivo was 30.5 mm (25,5 %) (p = 0.0001). The average shrinkage between in vivo and in vitro bowel samples was 51.0 mm.Conclusions. Measurement of the distal resection margin under different conditions influences the estimation of the oncological clearence in interpreting the results of pathological report and determining the results of treatment.


  • Open Access

    Total neoadjuvant therapy for locally advanced rectal cancer: a literature review

    by A. V. Polynovskiy, Z. Z. Mamedli, D. V. Kuzmichev, A. A. Tryakin, O. A. Kuznetsova, S. O. Kochkina, A. A. Aniskin, A. S. Gorbunova, D. V. Aleksancev, H. R. Temirsultanova

    The problem of locally advanced rectal cancer (LARC) treatment has not lost its importance and relevance over the past decades, due to the steady increase in the incidence. For a long time, neoadjuvant chemoradiotherapy (nCRT) before total mesorectal excision (TME) and followed systemic chemotherapy was widely accepted as the standard therapy for locally advanced rectal cancer. Although local control is more than satisfactory using this approach, the same cannot be said of distant metastases, which rate reaches 30 % or more and is mainly the cause of death of this category of patients. One of the reasons for this lack of improvement may be the rate of patients who complete the planned adjuvant chemotherapy, which is approximately 50 %. The reasons for that may be postoperative complications, long-term recovery after extensive surgical procedures, etc. Total Neoadjuvant Therapy (TNT) is an emerging approach for the treatment of LARC aimed at improving distant metastasis. This review will outline the main steps in the evolution of LARC treatment and the formation of the stages of total neoadjuvant therapy.

  • Open Access

    Surgical aspects of stoma formation in oncology. Literature review

    by A. S. Gorbunova, D. V. Kuzmichev, Z. Z. Mamedli, A. A. Aniskin, A. V. Polinovsky, D. V. Aleksantsev, A. V. Korshak

    The formation of intestinal stoma is performed during routine and emergency operations. This review provides a brief historical overview of the main stages of development of methods colo- and ileostomy. The article presents indications, as well as possible complications that may happen during operative treatment. It is occurred that there is little evidentiary material of colo- or ileostomy in evaluating complications that are associated with the various surgical methods of intestinal stoma formation. The purpose of this review is to summarize the current data on stoma formation and determine the method to use.


  • Open Access

    Immediate results of rectal resections for cancer in depending on the restoration of the integrity of the pelvic peritoneal floor: retrospective study

    by M. S. Lebedko, S. S. Gordeev, S. G. Gaydarov, Z. Z. Mamedli, V. Yu. Kosyrev, A. A. Aniskin, S. O. Kochkina

    Background. Colorectal anastomotic leakage remains on of the most significant challenges in rectal surgery.Objective: to assess the impact of pelvic peritoneal floor reconstruction on the incidence of postoperative complications associated with colorectal anastomosis.Materials and methods. In this retrospective cohort study, we analyzed medical records of rectal cancer patients who had undergone rectal resection with anastomosis formation between 2013 and 2020. we compared patients who had no pelvic peritoneal floor reconstruction (from 2013 to 2017) and those who had it (2018–2020). Only patients with favorable prognosis (tumor located at least 5 cm above the transitional anal fold and no history of chemoradiotherapy) were included. The primary outcome measure was the incidence of peritonitis and colorectal anastomosis leakage. Secondary outcome measures included overall incidence of complications (Clavien–Dindo), mortality rate, blood loss, and duration of surgery.Results. A total of 120 patients were included into the experimental group, while the control group was composed of 125 patients. Ten patients from the control group developed peritonitis (8.0 %), whereas in the experimental group, there were no cases of peritonitis (p = 0.002). Anastomotic leakage was registered in 12 individuals from the experimental group (12.5 %) and 14 controls (11.2 %) (p = 0.753). The overall incidence of postoperative complications was 23.3 % (n = 28) among patients who had pelvic peritoneal floor reconstruction and 18.4 % (n = 23) among those who did not have it (p = 0.342). Colostomy was required in 92 patients from the experimental group (76.7 %) and 78 patients from the control group (62.4 %) (p = 0.018). The postoperative mortality was 0.8 % in the control group (n = 1) and 0 % in the experimental group (p = 1).Conclusion. Pelvic peritoneal floor reconstruction reduces the risk of peritonitis, but does not affect the overall risk of anastomotic leakage. This method is effective for the prevention of severe postoperative complications.


  • Open Access

    Three-year outcomes of sandwich therapy in patients with locally advanced cancer of the middle and lower rectum

    by A. A. Aniskin, D. V. Kuzmichev, Z. Z. Mamedli, A. V. Polynovskiy

    Background. The most important criteria for the effectiveness of the treatment of locally advanced rectal cancer are indicators of overall survival (OS) and disease-free survival (DSF). Conducting systemic chemotherapy in addition to chemoradiotherapy at the preoperative stage can increase these indicators.Objective: to study analyze the indicators of 3-year OS and DFS, as well as the frequency of local relapses and distant metastases.Materials and methods. From 2013 to 2020, 72 patients with T≥3(CRM+)N0–2M0 lower and middle ampullar rectal cancer were included in the study using sandwich therapy. At the first stage, 2 courses of induction polychemotherapy were carried out according to the CapOx scheme (capecitabine 2000 mg/m2 orally for 14 days and oxaliplatin 130 mg/m2 intravenously once every 3 weeks). Further, chemoradiation therapy was carried out with a total focal dose of 50–56 Gy while taking capecitabine 1650 mg/m2 per day orally on the days of irradiation. After the end of chemotherapy, the patients underwent 2 courses of consolidating polychemotherapy according to the CapOx scheme (capecitabine 2000 mg/m2 orally for 14 days and oxaliplatin 130 mg/m2 intravenously once every 3 weeks). The control group consisted of 72 patients who underwent neoadjuvant treatment in accordance with current clinical guidelines (chemotherapy course with a total focal dose of 50–56 Gy while taking capecitabine 1650 mg/m2 per day orally on the days of irradiation).Results. In 19 (26.4 %) patients from the study group and in 6 (8.3 %) patients from the control group, the achievement of pCR was recorded (p = 0.006). The overall complication rate was 48 (66.7 %) in the study group and 37 (51.4 %) in the control group (p = 0.072), the frequency of grade III–IV toxicity was 8 (11.1 %) and 7 (9.7 %), respectively (p = 0.072). Sphincter-sparing surgical interventions were performed in 52 (72.2 %) and 40 (55.6 %) patients in the sandwich-therapy group and the control group of chemoradiation therapy, respectively (p = 0.037). Resection in the R0 volume was achieved in 71 (98.6 %) and 72 (100 %) patients, respectively (p = 0.316).Conclusion. The use of sandwich therapy is a promising trend in the treatment of patients with locally advanced rectal cancer. There were no significant differences in the frequency of 3-year OS (96.1 % versus 91.5 %, p = 0.247), DFS (89.8 % versus 84.0 %, p = 0.117) and local relapses (0 % versus 4.2 %, p = 0.997). In our study, statistically significant differences were obtained in the incidence of distant metastases (6.9 % versus 18.1 %, p = 0.05), which may indicate a positive trend towards an increase in OS and DFS rates.


  • Open Access

    Intensification of neoadjuvant therapy in patients with locally advanced rectal cancer

    by Z. Z. Mamedli, A. V. Polynovskiy, D. V. Kuzmichev, S. I. Tkachev, A. A. Aniskin

    The aim of the study: to increase the frequency of achieving pathologic complete response and increase disease-free survival in the investigational group of patients with locally advanced rectal cancer T3(MRF+)–4N0–2M0 by developing a new strategy for neoadjuvant therapy.Materials and methods. In total, 414 patients were assigned to treatment. Control group I included 89 patients who underwent radiotherapy (RT) 52–56 Gy/26–28 fractions with concurrent capecitabine twice daily 5 days per week. Control group II included 160 patients who underwent RT 52–56 Gy/26–28 fractions with concurrent capecitabine twice daily 5 days per week and oxaliplatin once a week, during the course of RT. Study group III consisted of 165 patients. This group combined RT 52–56 Gy/26–28 fractions with concurrent capecitabine twice daily 5 days per week and additional consecutive CapOx cycles. This group was divided into 2 subgroups: subgroup IIIa included 106 patients with consolidating chemotherapy (after CRT); subgroup IIIb included 59 patients who underwent “sandwich” treatment. Therapy consisted of conducting from 1 to 2 cycles of induction CapOx (up to CRT) and from 1 to 2 cycles of consolidating CapOx with an interval of 7 days. In the interval between the courses of drug therapy, RT 52–56 Gy/26–28 fractions was performed. According to the results of the control examination, further treatment tactics were determined. The primary end points were 5-year disease-free survival and the achievement of a pathologic complete response.Results. Pathologic complete response was significantly more often recorded in patients in the investigational group III (17.48 %; p = 0.021) compared with control groups (7.95 % in the I group and 8.28 % in the II group). 5-year disease-free survival in patients in the study groups was: 71.5 % in the III group, 65.6 % in the II group and 56.9 % in the I group.Conclusion. The shift in emphasis on strengthening the neoadjuvant effect on the tumor and improving approaches to drug therapy regimens have significantly improved disease-free survival of patients with locally advanced rectal cancer.


  • The frequency of achieving complete therapeutic pathomorphosis when using sandwich-therapy for locally advanced rectal cancer

    by N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russian Federatiоn, A.A. Aniskin, D.V. Kuzmichev, Z.Z. Mamedli, S.S. Gordeev, A.V. Polynovskiy, Zh.M. Mad'YArov, I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenov University)

    Частота достижения полного лечебного патоморфоза при использовании sandwich-терапии местнораспространенного рака прямой кишки